Ospemifene 60 mg: Clinical Trials

4 trials of Ospemifene 60 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 3 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 41Completed 1

Follow Ospemifene 60 mg: new trials by email Literature Review of Ospemifene 60 mg trials Research Report on Ospemifene 60 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders
Ospemifene 60 mg, fMRI experiments - Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause
Phase 4CompletedHospital Clinic of Barcelona252021-11-012025-09-15
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Ospemifene 60 mg, Placebo - Atrophy, Vaginal Diseases
Phase 3CompletedShionogi9192008-07-012018-05-18
A Clinical Study to Evaluate the Safety of Ospemifene
Ospemifene 60 mg, Placebo - Atrophy, Vaginal Diseases
Phase 3CompletedShionogi4262007-10-012018-05-18
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Ospemifene 30 mg, Ospemifene 60 mg, Placebo - Atrophy, Vaginal Diseases
Phase 3CompletedShionogi8262006-01-012013-06-28

Conditions studied

Atrophy (3)  ·  Vaginal Diseases (3)  ·  Coitus (1)  ·  Sexual Dysfunction, Physiological (1)

Sponsors

Shionogi (3)  ·  Hospital Clinic of Barcelona (1)

Countries

Spain (1)

Top investigators

Camil Castelo-Branco (1)

Results publications

PMID 23361170